Reviews
“Warum fragt man einen pharmazeutischen Chemiker, wenn es um Innovationen in der Arzneitherapie geht? Die Folge zu Innovationen gegen Altersprozesse (was immer das sein soll) mit Dingermann ist unterirdisch. Allgemeines Blabla, eine Fehlinterpretation von SGLT2-Inhibitoren, und als Krönung:...”Read full review »
Harald HHW Schmidt via Apple Podcasts ·
Germany ·
09/17/22
Do you host a podcast?
Track your ranks and reviews from Spotify, Apple Podcasts and more.
See hourly chart positions and more than 30 days of history.
Get Chartable Analytics »
See hourly chart positions and more than 30 days of history.
Listen now
Links
Twitter
Facebook
Instagram
Patreon
Genres
Artwork or description wrong?
Request an update »
Updates may take a few minutes.
Do you host a podcast?
Track your ranks and reviews from Spotify, Apple Podcasts and more.
See hourly chart positions and more than 30 days of history.
Get Chartable Analytics »
See hourly chart positions and more than 30 days of history.
